Perwyn has entered an agreement to sell its stake in Wgnstar to ABM in a cash transaction valued at approximately $275 million.
Pharmanoid is a manufacturing site specializing in the production of HPAPIs for ophthalmology. Inke, which is backed by Keensight Capital, has acquired Pharmanoid from Gentec Pharmaceutical Group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback